RONS clearing TePt @ sodium carboxymethyl cellulose nanozymes for chronic enteritis therapy
Xinyan Hu1, Gongxin Zhang1, Lida Tang1
1State Key Laboratory for Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials, National & Local Joint Engineering Research Center of Preparation Technology of Nanomaterials, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
Abstract:
Chronic enteritis is a prevalent inflammatory disease that can progress to acute enteritis and even intestinal cancer if not promptly treated. This inflammation is often associated with the overproduction of reactive oxygen and nitrogen species (RONS), which disrupt the cellular redox homeostasis and induce significant damage to cells and tissues. Therefore, the targeted removal of RONS at inflamed sites has emerged as a promising therapeutic strategy for chronic enteritis. In this study, the TePt nanorods (TP) with good physiological stability, biosafety and antioxidant activities were developed to alleviate chronic enteritis. TP demonstrated pH-dependent enzymatic activities, effectively scavenging reactive oxygen species through their superoxide dismutase and catalase activities, as well as clearing reactive nitrogen species under neutral conditions. At the cellular level, TP could eliminate intracellular RONS and protect cells from oxidative stress-induced damage. In a dextran sulfate sodium (DSS)-induced mouse model of chronic enteritis, the intragastric administration of TP combined with sodium carboxymethyl cellulose (CMC) significantly inhibited the expression of proinflammatory cytokine, restored redox homeostasis, and promoted bowel repair without noticeable adverse effects. This study provides new insights into the design of antioxidant nanozymes for the treatment of chronic enteritis.
Related Concept Videos
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...


